Regulacje i polityka gospodarcza · 13/12/1999

National Cancer Institute Seeks Collaborator for CRADA to Develop Cancer Treatment Methods Using NOS2 Modulators

The National Cancer Institute is seeking a partner to aid in the development and commercialization of methods for treating cancer using modulators of nitric oxide synthase 2 (NOS2) activity, which has shown potential in promoting tumor progression and angiogenesis.